PRASUGREL - TRIMA 10 MG Israel - English - Ministry of Health

prasugrel - trima 10 mg

trima israel pharmaceutical products maabarot ltd - prasugrel - film coated tablets - prasugrel 10 mg - prasugrel - prasugrel - trima 10 mg, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci). the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 or weight below 60 kg.

EFFIENT 5 MG Israel - English - Ministry of Health

effient 5 mg

eli lilly israel ltd - prasugrel as hydrochloride - film coated tablets - prasugrel as hydrochloride 5 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci).the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 or weight below 60 kg.

EFFIENT 10 MG Israel - English - Ministry of Health

effient 10 mg

eli lilly israel ltd - prasugrel as hydrochloride - film coated tablets - prasugrel as hydrochloride 10 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci). the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 or weight below 60 kg.

PRASUGREL LUPIN prasugrel 10 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

prasugrel lupin prasugrel 10 mg film-coated tablet blister pack

southern cross pharma pty ltd - prasugrel, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; crospovidone; microcrystalline cellulose; croscarmellose sodium; sucrose stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - prasugrel, co-administered with aspirin, is indicated for the prevention of atherothrombotic events (myocardial infarction, stroke and cardiovascular death) in patients with acute coronary syndromes (moderate to high risk unstable angina (ua), non st-segment elevation myocardial infarction (nstemi) or st-segment elevation myocardial infarction (stemi)) who are to undergo percutaneous coronary intervention (pci).

PRASUGREL LUPIN prasugrel 5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

prasugrel lupin prasugrel 5 mg film-coated tablet blister pack

southern cross pharma pty ltd - prasugrel, quantity: 5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; crospovidone; microcrystalline cellulose; lactose monohydrate; sucrose stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow - prasugrel, co-administered with aspirin, is indicated for the prevention of atherothrombotic events (myocardial infarction, stroke and cardiovascular death) in patients with acute coronary syndromes (moderate to high risk unstable angina (ua), non st-segment elevation myocardial infarction (nstemi) or st-segment elevation myocardial infarction (stemi)) who are to undergo percutaneous coronary intervention (pci).

Prasugrel Rowex 5 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

prasugrel rowex 5 mg film-coated tablets

rowex ltd - prasugrel besilate - film-coated tablet - 5 milligram(s) - platelet aggregation inhibitors excl. heparin; prasugrel

Prasugrel Rowex 10 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

prasugrel rowex 10 mg film-coated tablets

rowex ltd - prasugrel - film-coated tablet - 10 milligram(s) - platelet aggregation inhibitors excl. heparin; prasugrel

Prasugrel Krka 5 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

prasugrel krka 5 mg film-coated tablets

krka, d.d., novo mesto - prasugrel - film-coated tablet - 5 milligram(s) - platelet aggregation inhibitors excl. heparin; prasugrel

Prasugrel Krka 10 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

prasugrel krka 10 mg film-coated tablets

krka, d.d., novo mesto - prasugrel - film-coated tablet - 10 milligram(s) - platelet aggregation inhibitors excl. heparin; prasugrel

Prasugrel Accord 10 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

prasugrel accord 10 mg film-coated tablets

accord healthcare ireland ltd. - prasugrel - film-coated tablet - 10 milligram(s) - platelet aggregation inhibitors excl. heparin; prasugrel